Revenue
$24.1M
Net Income
-$243.3M
▲ 17.3% YoY
EPS
$-2.86
▲ 72.4% YoY
Cash
$89.7M
▼ 47.1% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Drappa Jorn Chief Medical Officer | Vest | May 22, 2026 | 11.3K | $8.84 | $100K | Form 4 ↗ |
Drappa Jorn Chief Medical Officer | Vest | May 22, 2026 | 15.5K | $5.06 | $79K | Form 4 ↗ |
Foresite Labs, LLC | Sell | Apr 1, 2026 | 1.18M | $0.00 | $0 | Form 4 ↗ |
Foresite Labs, LLC | Buy | Apr 1, 2026 | 1.12M | $0.00 | $0 | Form 4 ↗ |
Foresite Labs, LLC | Sell | Apr 1, 2026 | 1.12M | $0.00 | $0 | Form 4 ↗ |
Foresite Labs, LLC | Buy | Apr 1, 2026 | 680.5K | $0.00 | $0 | Form 4 ↗ |
Foresite Capital Management VI LLC | Sell | Apr 1, 2026 | 1.18M | $0.00 | $0 | Form 4 ↗ |
Foresite Capital Management VI LLC | Buy | Apr 1, 2026 | 1.12M | $0.00 | $0 | Form 4 ↗ |
Foresite Capital Management VI LLC | Sell | Apr 1, 2026 | 1.12M | $0.00 | $0 | Form 4 ↗ |
Foresite Capital Management VI LLC | Buy | Apr 1, 2026 | 680.5K | $0.00 | $0 | Form 4 ↗ |
Tananbaum James B. | Sell | Apr 1, 2026 | 1.18M | $0.00 | $0 | Form 4 ↗ |
Tananbaum James B. | Buy | Apr 1, 2026 | 1.12M | $0.00 | $0 | Form 4 ↗ |
Tananbaum James B. | Sell | Apr 1, 2026 | 1.12M | $0.00 | $0 | Form 4 ↗ |
Tananbaum James B. | Buy | Apr 1, 2026 | 680.5K | $0.00 | $0 | Form 4 ↗ |